Cargando…

Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

Detalles Bibliográficos
Autores principales:	Vuitton, Lucine, Bourrier, Anne, Uzzan, Mathieu, Nachury, Maria, Amiot, Aurelien, Roblin, Xavier, Allez, Matthieu, Altwegg, Romain, Vidon, M.M., Bourreille, Arnaud, Serrero, Melanie, Pelletier, Anne-Laure, Filippi, Jerome, Gilletta, Cyrielle, Simon, Marion, Laharie, David, Nahon, Stephane, Duveau, Nicolas, Biron, Amelie, Viennot, Stephanie, Abitbol, Vered, Elgharabawy, Yasmine, Peyrin-Biroulet, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212677/ http://dx.doi.org/10.1016/S0016-5085(22)61421-5

Ejemplares similares

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study
por: Amiot, Aurelien, et al.
Publicado: (2022)

Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn’s Disease: A Multicentre Case-Control Study
por: Chappe, Capucine, et al.
Publicado: (2023)

Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Rayer, Cassandra, et al.
Publicado: (2023)

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Cassandra, Rayer, et al.
Publicado: (2022)

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
por: Bouhnik, Yoram, et al.
Publicado: (2018)

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2022)

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
por: Louis, Edouard, et al.
Publicado: (2023)

Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS
por: Lelong, Margaux, et al.
Publicado: (2022)

Fray Bernardino de Sahagún, 1499-1590 /
por: Nicolau D'Olwer, Lluís, 1888-1961
Publicado: (1952)

The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics
por: Lelong, Margaux, et al.
Publicado: (2023)

P1499: GENETIC FACTORS OF IRON OVERLOAD IN HEREDITARY SPHEROCYTOSIS
por: Donaty, Lucie, et al.
Publicado: (2023)

Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies
por: Calméjane, Louis, et al.
Publicado: (2023)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

1499. Gonorrhea and Chlamydia Infections in the Department of Veterans Affairs (VA), 2013–2017
por: Schirmer, Patricia, et al.
Publicado: (2018)

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease
por: Dulai, Parambir S., et al.
Publicado: (2019)

A plea for the pathogenic role of immune complexes in severe Covid-19
por: Vuitton, Dominique A., et al.
Publicado: (2020)

Syphilis in Maria Salviati (1499–1543), Wife of Giovanni de’ Medici of the Black Bands
Publicado: (2020)

Syphilis in Maria Salviati (1499–1543), Wife of Giovanni de’ Medici of the Black Bands
por: Fornaciari, Antonio, et al.
Publicado: (2020)

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience
por: Furfaro, Federica, et al.
Publicado: (2020)

Non-surgical and non-chemical attempts to treat echinococcosis: do they work?
por: Tamarozzi, Francesca, et al.
Publicado: (2014)

1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
por: Kyung Yoon, Young, et al.
Publicado: (2019)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV
por: McLaughlin, Taryn, et al.
Publicado: (2023)

Prevalence of esophageal squamous papilloma (ESP) and associated cancer in northeastern France
por: d’Huart, Marie-Caroline, et al.
Publicado: (2015)

Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab
por: Roblin, Xavier, et al.
Publicado: (2015)

First report of c. 1499G>C mutation in a 6-month-child with cystic fibrosis
por: Sahami, Abbas, et al.
Publicado: (2014)

De-Novo Assembly and Analysis of the Heterozygous Triploid Genome of the Wine Spoilage Yeast Dekkera bruxellensis AWRI1499
por: Curtin, Chris D., et al.
Publicado: (2012)

Will the Quality of Research Remain the Same During the COVID-19 Pandemic?
por: Peyrin-Biroulet, Laurent
Publicado: (2020)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

Faster and less invasive tools to identify patients with ileal colonization by adherent‐invasive E. coli in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters
por: Kim, HoUng, et al.
Publicado: (2021)

rs2476601 polymorphism in PTPN22 is associated with Crohn’s disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls
por: Hedjoudje, Abdellah, et al.
Publicado: (2017)

Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease
por: Abreu, Maria T, et al.
Publicado: (2020)

Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021)

Evolution of IL-23 Blockade in Inflammatory Bowel Disease
por: Danese, Silvio, et al.
Publicado: (2022)

Larval Echinococcus multilocularis infection reduces dextran sulphate sodium‐induced colitis in mice by attenuating T helper type 1/type 17‐mediated immune reactions
por: Wang, Junhua, et al.
Publicado: (2017)

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508
por: Home, Philip, et al.
Publicado: (2014)

Abstract No. : ABS1499: Role of platelet-rich-plasma versus dextrose-prolotherapy in the management of partial rotator cuff tear- A randomised controlled trial.
Publicado: (2022)

Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agf8177pp2sebir5nint4oc5qo